Degenerative Disc Disease: AI-Powered MRI Analysis

The Pfirrmann classification grades lumbar disc degeneration on sagittal T2-weighted MRI into five levels. Grade I discs are homogeneously bright white (high water content). Grade II shows slight signal inhomogeneity with a horizontal gray band but preserved height. Grade III demonstrates moderate signal loss and slight height reduction. Grade IV discs are dark with moderate height loss and an irregular nucleus–annulus boundary. Grade V discs are completely black, collapsed, and show no distinction between nucleus and annulus. Higher Pfirrmann grades correlate with symptom severity but not perfectly — many grade IV–V discs are asymptomatic, which complicates surgical decision-making.

Modic changes are MRI signal alterations in the vertebral endplates and adjacent bone marrow adjacent to degenerated discs. Type I (low T1, high T2) represents bone marrow edema and vascular granulation tissue, associated with active pain and inflammation, and may respond to intradiscal biologic or antibiotic treatments in select cases. Type II (high T1, high T2) indicates fatty marrow conversion, generally a stable, chronic finding. Type III (low T1, low T2) represents subchondral sclerosis analogous to osteosclerosis. Conversion from type I to type II is common over time. The presence of Modic type I changes at a symptomatic level supports that level as pain-generating and guides diagnostic injections and fusion planning.

Disc degeneration is near-universal with aging, but DDD as a clinical diagnosis requires correlating imaging findings with concordant symptoms. By age 50, over 85% of people show some Pfirrmann grade II–III changes without pain. The clinical diagnosis is supported by provocation discography demonstrating pain reproduction at low pressures (less than 50 psi above opening pressure) at the degenerated level and absence of concordant pain at adjacent control discs, though discography remains controversial given false-positive rates and risks. Genetic predisposition accounts for up to 70% of disc degeneration variance, meaning many individuals with severe imaging findings have minimal symptoms. Treatment is guided by functional limitation rather than imaging grade alone.